Paper42663294
Research progress on lactate metabolism in lung cancer: Tumorigenesis, drug resistance and clinical translation (Review).
Zhang Y and 7 others. Oncol Rep, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Research progress on lactate metabolism in lung cancer: Tumorigenesis, drug resistance and clinical translation (Review). Papers, record 42663294. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42663294
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Research progress on lactate metabolism in lung cancer: Tumorigenesis, drug resistance and clinical translation (Review).
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lung Neoplasms | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Lactic Acid | Major topic |
| Humans | |
| Metabolic Reprogramming | |
| Tumor Microenvironment | |
| Animals | |
| Epithelial-Mesenchymal Transition | |
| Signal Transduction | |
| Monocarboxylic Acid Transporters | |
| Carcinogenesis | |
| Translational Research, Biomedical |
Source PubMed
References95
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36610137 | Formosanin C inhibits non-small-cell lung cancer progression by blocking MCT4/CD147-mediated lactate export. | Phytomedicine | 2023 | https://conductscience.org/library/papers/36610137 | PubMed |
| 2 | 41190808 | Lactylation Enhances the Activity of Lactate Dehydrogenase A and Promotes the Chemoresistance to Cisplatin Through Facilitating DNA Nonhomologous End Junction in Lung Adenocarcinoma. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41190808 | PubMed |
| 3 | 40161374 | A novel lactylation-related gene signature to predict prognosis and treatment response in lung adenocarcinoma. | Front Oncol | 2025 | https://conductscience.org/library/papers/40161374 | PubMed |
| 4 | 31343662 | Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer. | JAMA Oncol | 2019 | https://conductscience.org/library/papers/31343662 | PubMed |
| 5 | 33153193 | Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33153193 | PubMed |
| 6 | 33580429 | Lactate anions participate in T cell cytokine production and function. | Sci China Life Sci | 2021 | https://conductscience.org/library/papers/33580429 | PubMed |
| 7 | 33192532 | Combining 18F-FDG PET/CT and Serum Lactate Dehydrogenase for Prognostic Evaluation of Small Cell Lung Cancer. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33192532 | PubMed |
| 8 | 40917754 | Lactate modulates the function of myeloid-derived suppressor cells via Ten-Eleven-Translocation-2-mediated demethylation of glucocorticoid-inducible kinase 1 in lung cancer model. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40917754 | PubMed |
| 9 | 35090047 | Pre- and on-treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non-small cell lung cancer. | Cancer | 2022 | https://conductscience.org/library/papers/35090047 | PubMed |
| 10 | 15917240 | Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). | J Biol Chem | 2005 | https://conductscience.org/library/papers/15917240 | PubMed |
| 11 | 40166469 | Potential role of lactylation in intrinsic immune pathways in lung cancer. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40166469 | PubMed |
| 12 | 34086382 | Visualizing the effects of lactate dehydrogenase (LDH) inhibition and LDH-A genetic ablation in breast and lung cancer with hyperpolarized pyruvate NMR. | NMR Biomed | 2021 | https://conductscience.org/library/papers/34086382 | PubMed |
| 13 | 37965331 | Histone lactylation regulates cancer progression by reshaping the tumor microenvironment. | Front Immunol | 2023 | https://conductscience.org/library/papers/37965331 | PubMed |
| 14 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 15 | 41271679 | HAT1 functions as a lactyltransferase and mediates RPA1 lactylation to promote DNA repair and radioresistance in lung adenocarcinoma. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41271679 | PubMed |
| 16 | 29327044 | Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer. | JAMA Oncol | 2018 | https://conductscience.org/library/papers/29327044 | PubMed |
| 17 | 31737570 | Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches. | Front Oncol | 2019 | https://conductscience.org/library/papers/31737570 | PubMed |
| 18 | 33968927 | Evaluation of Monocarboxylate Transporter 4 (MCT4) Expression and Its Prognostic Significance in Circulating Tumor Cells From Patients With Early Stage Non-Small-Cell Lung Cancer. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/33968927 | PubMed |
| 19 | 40571210 | Benserazide‑mediated targeting hexokinase 2 enhances the cytotoxicity of cisplatin in non-small cell lung cancer cell models. | Biochem Pharmacol | 2025 | https://conductscience.org/library/papers/40571210 | PubMed |
| 20 | 22153830 | Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4. | Lung Cancer | 2012 | https://conductscience.org/library/papers/22153830 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42663294
GET https://conductscience.org/api/papers/v1/42663294/references?page=2